Select Bibliography

Filter by any of these (after searching):

CALGB-9583

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 6 items

Clinical and Prognostic Implications of PTPN11 Mutations in Acute Myeloid Leukemia

Fobare, Sydney , Kohlschmidt, Jessica , Ozer, Hatice Gulcin ... - ASH - Blood - 2020

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9583

Is progression free survival a predictor of overall survival in men with castration recurrent prostate cancer (CRPC)?

Halabi, S. , Ou, S. , Vogelzang, N. J. ... - ASCO GU - - 2008

Abstract - Secondary-not-in-original - Meta-Analysis - GU - CALGB-9181 , CALGB-9182 , CALGB-90004 , CALGB-90006 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813 , INT-0159

Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.

Halabi, Susan , Ou, San-San , Vogelzang, Nicholas J ... - - Cancer - 2007

Manuscript - Secondary-not-in-original - Meta-Analysis - GU - CALGB-9181 , CALGB-9182 , CALGB-90004 , CALGB-90006 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813

The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials.

Halabi, Susan , Vogelzang, Nicholas J , Ou, San-San ... - - J Urol - 2007

Manuscript - Secondary-not-in-original - Meta-Analysis - GU - CALGB-9181 , CALGB-9182 , CALGB-90004 , CALGB-9000 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813 , INT-0159

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

Ryan, Charles J , Halabi, Susan , Ou, San-San , Vogelzang, Nicholas J ... - - Clin Cancer Res - 2007

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-9583

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

Small, Eric J , Halabi, Susan , Dawson, Nancy A , Stadler, Walter M ... - - J Clin Oncol - 2004

Manuscript - Primary - Primary - GU - CALGB-9583